1 Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
2 Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium.
3 Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
4 Cistim Leuven, Leuven, Belgium.
5 Janssen Research & Development, Janssen Pharmaceutica, Beerse, Belgium.
6 Janssen Infectious Diseases Discovery, Janssen-Cilag, Val de Reuil, France.
7 Galapagos, Romainville, France.
8 Charles River Beerse, Discovery, Beerse, Belgium.
9 Institut National de la Recherche Scientifique, Centre Armand-Frappier Santé Biotechnologie, Quebec, Quebec, Canada.
10 Unité des Virus Émergents (UVE), Aix-Marseille Univ, IRD 190 Inserm 1207, IHU Méditerranée Infection, Marseille, France.
11 Aligos, Leuven, Belgium.
12 Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium.
13 German Center for Infection Research, Heidelberg Partner Site, Heidelberg, Germany.
14 Janssen Global Public Health, Janssen Pharmaceutica, Beerse, Belgium. mvloock@its.jnj.com.
15 Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. johan.neyts@kuleuven.be.
16 Global Virus Network (GVN), Baltimore, MD, USA. johan.neyts@kuleuven.be.